Specialty Pharmacy News

Image description

Johnson & Johnson to buy Actelion for $30B

Actelion will spin off its drug discovery operations and early-stage clinical development assets into a newly created company to its shareholders in the form of a dividend immediately prior to the deal closing.

Image description

PhRMA launches Go Boldly campaign

The campaign is aimed at highlighting those in the industry driving innovation and pointing to the opportunity that exists in tackling complex health conditions. 

Image description

Mayne Pharma launches Fabior, Sorilux

Mayne Pharma acquired the products from GSK in August 2016, and they complement the company’s Doryx, the first branded product in its specialty brands division that it launched in 2015. 

Image description

Sanofi, ImmuNext enter specialty drug development agreement

Under the agreement, ImmuNext will grant Sanofi and exclusive worldwide license to develop and commercialize INX-021, a monoclonal antibody in preclinical development that suppresses the activity of a cellular pathway that’s overactive in many autoimmune diseases.